BBOTVSEOCN• 3 Months (Normalized)
BBOT vs EOCN (BridgeBio Oncology Therapeutics Inc. vs Eocene Ltd.)
Showing Closing Date Range from Jul 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.44
-62.16%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
EOCN Performance $3.46
-0.92%
Eocene Ltd.
Normalized Baseline0.00%
Alpha Spread Margin EOCN LEADS
-61.24 pts
EOCN outperforming by 61.24 percentage points
BBOTEOCN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT EOCN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | BBOT Price | BBOT Gain (%) | EOCN Price | EOCN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $3.44 | -62.16% | $3.46 | -0.92% | -61.24% |
| Oct 06, 2026 | $3.50 | -61.50% | $3.36 | -3.72% | -57.78% |
| Oct 05, 2026 | $3.60 | -60.40% | $3.45 | -1.15% | -59.25% |
| Oct 02, 2026 | $3.89 | -57.21% | $3.61 | +3.44% | -60.65% |
| Oct 01, 2026 | $- | $3.41 | -2.44% | - | |
| Sep 30, 2026 | $4.10 | -54.90% | $3.49 | +0.00% | -54.90% |
| Sep 29, 2026 | $3.92 | -56.88% | $- | - | |
| Sep 28, 2026 | $3.81 | -58.09% | $- | - | |
| Sep 25, 2026 | $3.95 | -56.55% | $- | - | |
| Sep 24, 2026 | $3.99 | -56.11% | $- | - | |
| Sep 23, 2026 | $4.16 | -54.24% | $- | - | |
| Sep 22, 2026 | $4.66 | -48.73% | $- | - | |
| Sep 21, 2026 | $4.66 | -48.73% | $- | - | |
| Sep 18, 2026 | $4.77 | -47.52% | $- | - | |
| Sep 17, 2026 | $4.89 | -46.20% | $- | - |
Page 1 of 5